These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21514133)

  • 1. Economic constraint and modes of consumption of addictive goods.
    Ben Lakhdar C; Bastianic T
    Int J Drug Policy; 2011 Sep; 22(5):360-5. PubMed ID: 21514133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illegal drug use and the economic recession--what can we learn from the existing research?
    Bretteville-Jensen AL
    Int J Drug Policy; 2011 Sep; 22(5):353-9. PubMed ID: 21555212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessions and the participation of youth in the selling and use of illicit drugs.
    Arkes J
    Int J Drug Policy; 2011 Sep; 22(5):335-40. PubMed ID: 21482093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global recession's effect on drug demand--diluted by inertia.
    Caulkins JP
    Int J Drug Policy; 2011 Sep; 22(5):374-5. PubMed ID: 21429731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use and recessions: what can be learned from economic analyses of alcohol?
    Pacula RL
    Int J Drug Policy; 2011 Sep; 22(5):326-34. PubMed ID: 21855312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unemployment and drug treatment.
    Storti CC; De Grauwe P; Sabadash A; Montanari L
    Int J Drug Policy; 2011 Sep; 22(5):366-73. PubMed ID: 21840699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. This recession is wearing me out! Health-related quality of life and economic downturns.
    Davalos ME; French MT
    J Ment Health Policy Econ; 2011 Jun; 14(2):61-72. PubMed ID: 21881162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for comparing drug policies--the utility of composite drug harm indexes.
    Ritter A
    Int J Drug Policy; 2009 Nov; 20(6):475-9. PubMed ID: 19356915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurobiology of addiction to drugs of abuse].
    Gil-Verona JA; Pastor JF; de Paz F; Barbosa M; Macias-Fernández JA; Maniega MA; Rami-González L; Cañizares-Alejos S
    Rev Neurol; 2003 Feb 15-28; 36(4):361-5. PubMed ID: 12599136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are drug detection dogs and mass-media campaigns likely to be effective policy responses to psychostimulant use and related harm? Results from an agent-based simulation model.
    Dray A; Perez P; Moore D; Dietze P; Bammer G; Jenkinson R; Siokou C; Green R; Hudson SL; Maher L
    Int J Drug Policy; 2012 Mar; 23(2):148-53. PubMed ID: 21742481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program].
    Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X
    Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
    Barratt MJ; Lenton S; Maddox A; Allen M
    Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.